An analysis of CMS data between 2009 and 2011 showed higher costs per beneficiary were a result of medication choice, with more expensive chemotherapy drugs used in outpatient settings. It also showed that chemotherapy days were between 9 and 12 percent higher in outpatient care settings.
Overall discrepancies in cancer treatment costs may be a result of differences in updates to the Medicare Physician Fee Schedule and the Outpatient Prospective Payment system, according to the report.
More Articles on Quality:
Study: Futile Care is Frequent, Costly
Henry Ford Health System: Patient Safety Organizations Provide Value
Readmissions Measures Should Integrate Patient Experience, Community Health, Panel Says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
